Citations

Citations to this article as recorded by  

• Diabetes: a review of its pathophysiology, and advanced methods of mitigation
  Sarika Gupta, Nitin Sharma, Sandeep Arora, Saurabh Verma
  Current Medical Research and Opinion.2024; 40(5): 773.     CrossRef
• Lobeglitazone, a novel thiazolidinedione, for secondary prevention in patients with ischemic stroke: a nationwide nested case-control study
  Joonsang Yoo, Jimin Jeon, Minyoul Baik, Jinkwon Kim
  Cardiovascular Diabetology.2023;[Epub]     CrossRef
• Molecular Processes Involved in the Shared Pathways between Cardiovascular Diseases and Diabetes
  Julita Tokarek, Emilian Budny, Maciej Saar, Kamila Stańczak, Ewa Wojtanowska, Ewelina Młynarska, Jacek Rysz, Beata Franczyk
  Biomedicines.2023; 11(10): 2611.     CrossRef

As a member of the class IIa histone deacetylases (HDACs), HDAC9 catalyzes the deacetylation of histones and transcription factors, commonly leading to the suppression of gene transcription. The activity of HDAC9 is regulated transcriptionally and post-translationally. HDAC9 is known to play an essential role in regulating myocyte and adipocyte differentiation and cardiac muscle development. Also, recent studies have suggested that HDAC9 is involved in the pathogenesis of chronic diseases, including cardiovascular diseases, osteoporosis, autoimmune disease, cancer, obesity, insulin resistance, and liver fibrosis. HDAC9 modulates the expression of genes related to the pathogenesis of chronic diseases by altering chromatin structure in their promotor region or reducing the transcriptional activity of their respective transcription factors. This review summarizes the current knowledge of the regulation of HDAC9 expression and activity. Also, the roles of HDAC9 in the pathogenesis of chronic diseases are discussed, along with potential underlying mechanisms.

Citations

Citations to this article as recorded by  

• Impact of housing temperature on adipose tissue HDAC9 expression and adipogenic differentiation in high fat‐fed mice
  Samah Ahmadieh, Brandee Goo, Abdalrahman Zarzour, David Kim, Hong Shi, Praneet Veerapaneni, Ronnie Chouhaita, Nicole K. H. Yiew, Carla Dominguez Gonzalez, Akash Chakravartty, James Pennoyer, Nazeera Hassan, Tyler W. Benson, Mourad Ogbi, David J. Fulton, R
  Obesity.2024; 32(1): 107.     CrossRef
• HDAC9 inhibition reduces skeletal muscle atrophy and enhances regeneration in mice with cigarette smoke-induced COPD
  Guixian Zheng, Chao Li, Xiaoli Chen, Zhaohui Deng, Ting Xie, Zengyu Huo, Xinyan Wei, Yanbing Huang, Xia Zeng, Yu Luo, Jing Bai
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2024; 1870(3): 167023.     CrossRef
• Identification of HDAC9 and ARRDC4 as potential biomarkers and targets for treatment of type 2 diabetes
  Jing Liu, Lingzhen Meng, Zhihong Liu, Ming Lu, Ruiying Wang
  Scientific Reports.2024;[Epub]     CrossRef
• HDAC9 as a Privileged Target: Reviewing its Role in Different Diseases and Structure-activity Relationships (SARs) of its Inhibitors
  Totan Das, Samima Khatun, Tarun Jha, Shovanlal Gayen
  Mini-Reviews in Medicinal Chemistry.2024; 24(7): 767.     CrossRef
• The role of histone deacetylases in inflammatory respiratory diseases: an update
  Sicen Pan, Xiangdong Wang, Jian Jiao, Luo Zhang
  Expert Review of Clinical Immunology.2024; : 1.     CrossRef
• The Human Genetic Differences in the Outcomes of mRNA Vaccination against COVID-19: A Prospective Cohort Study
  Ha-Eun Ryu, Jihyun Yoon, Ja-Eun Choi, Seok-Jae Heo, Kyung-Won Hong, Dong-Hyuk Jung
  Vaccines.2024; 12(6): 626.     CrossRef
• Targeting histone deacetylases for cancer therapy: Trends and challenges
  Tao Liang, Fengli Wang, Reham M. Elhassan, Yongmei Cheng, Xiaolei Tang, Wengang Chen, Hao Fang, Xuben Hou
  Acta Pharmaceutica Sinica B.2023; 13(6): 2425.     CrossRef
• Therapeutic approach of natural products that treat osteoporosis by targeting epigenetic modulation
  Guokai Zhang, Zhenying Liu, Zihan Li, Bing Zhang, Pengyu Yao, Yun Qiao
  Frontiers in Genetics.2023;[Epub]     CrossRef
• Research Progress on Histone Deacetylase Inhibitors
  玉姜 汤
  Hans Journal of Medicinal Chemistry.2023; 11(02): 116.     CrossRef
• HDAC9 Inhibition as a Novel Treatment for Stroke
  Hugh S. Markus
  Stroke.2023; 54(12): 3182.     CrossRef
• Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of Klotho
  Min Liu, Yang Zhang, Ping Zhan, Wenjuan Sun, Chuanqiao Dong, Xiaohan Liu, Yujie Yang, Xiaojie Wang, Yusheng Xie, Chengjiang Gao, Huili Hu, Benkang Shi, Ziying Wang, Chun Guo, Fan Yi
  Pharmacological Research.2023; 198: 107009.     CrossRef
• Molecular mechanism and therapeutic potential of HDAC9 in intervertebral disc degeneration
  Ming Lei, Hui Lin, Deyao Shi, Pan Hong, Hui Song, Bomansaan Herman, Zhiwei Liao, Cao Yang
  Cellular & Molecular Biology Letters.2023;[Epub]     CrossRef
• Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia A
  Sylvia Fong, Bridget Yates, Choong-Ryoul Sihn, Aras N. Mattis, Nina Mitchell, Su Liu, Chris B. Russell, Benjamin Kim, Adebayo Lawal, Savita Rangarajan, Will Lester, Stuart Bunting, Glenn F. Pierce, K. John Pasi, Wing Yen Wong
  Nature Medicine.2022; 28(4): 789.     CrossRef
• Active RhoA Exerts an Inhibitory Effect on the Homeostasis and Angiogenic Capacity of Human Endothelial Cells
  Michael Hauke, Robert Eckenstaler, Anne Ripperger, Anna Ender, Heike Braun, Ralf A. Benndorf
  Journal of the American Heart Association.2022;[Epub]     CrossRef
• HDAC9 Contributes to Serous Ovarian Cancer Progression through Regulating Epithelial–Mesenchymal Transition
  Long Xu, Jian Wang, Buhan Liu, Jiaying Fu, Yuanxin Zhao, Sihang Yu, Luyan Shen, Xiaoyu Yan, Jing Su
  Biomedicines.2022; 10(2): 374.     CrossRef
• Common protein-coding variants influence the racing phenotype in galloping racehorse breeds
  Haige Han, Beatrice A. McGivney, Lucy Allen, Dongyi Bai, Leanne R. Corduff, Gantulga Davaakhuu, Jargalsaikhan Davaasambuu, Dulguun Dorjgotov, Thomas J. Hall, Andrew J. Hemmings, Amy R. Holtby, Tuyatsetseg Jambal, Badarch Jargalsaikhan, Uyasakh Jargalsaikh
  Communications Biology.2022;[Epub]     CrossRef
• Proposed minimal essential co-expression and physical interaction networks involved in the development of cognition impairment in human mid and late life
  Zahra Salehi, Masoud Arabfard, Omid Sadatpour, Mina Ohadi
  Neurological Sciences.2021; 42(3): 951.     CrossRef
• Emerging roles of SIRT6 in human diseases and its modulators
  Gang Liu, Haiying Chen, Hua Liu, Wenbo Zhang, Jia Zhou
  Medicinal Research Reviews.2021; 41(2): 1089.     CrossRef
• Quis Custodiet Ipsos Custodes (Who Controls the Controllers)? Two Decades of Studies on HDAC9
  Claudio Brancolini, Eros Di Giorgio, Luigi Formisano, Teresa Gagliano
  Life.2021; 11(2): 90.     CrossRef
• circ_0003204 Regulates Cell Growth, Oxidative Stress, and Inflammation in ox-LDL-Induced Vascular Endothelial Cells via Regulating miR-942-5p/HDAC9 Axis
  Huan Wan, Ting You, Wei Luo
  Frontiers in Cardiovascular Medicine.2021;[Epub]     CrossRef
• Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer
  Chun Yang, Stéphane Croteau, Pierre Hardy
  Cellular Oncology.2021; 44(5): 997.     CrossRef
• Dual HDAC/BRD4 inhibitors against cancer
  Negar Omidkhah, Farzin Hadizadeh, Razieh Ghodsi
  Medicinal Chemistry Research.2021; 30(10): 1822.     CrossRef
• miR‐211‐5p is down‐regulated and a prognostic marker in bladder cancer
  Weisheng Wang, Zhiming Liu, Xuegang Zhang, Junning Liu, Junqing Gui, Maorong Cui, Yong Li
  The Journal of Gene Medicine.2020;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Sitagliptin Mitigates Diabetic Nephropathy in a Rat Model of Streptozotocin-Induced Type 2 Diabetes: Possible Role of PTP1B/JAK-STAT Pathway
  Sarah M. AL-Qabbaa, Samaher I. Qaboli, Tahani K. Alshammari, Maha A. Alamin, Haya M. Alrajeh, Lama A. Almuthnabi, Rana R. Alotaibi, Asma S. Alonazi, Anfal F. Bin Dayel, Nawal M. Alrasheed, Nouf M. Alrasheed
  International Journal of Molecular Sciences.2023; 24(7): 6532.     CrossRef
• Evaluation of the efficacy of dipeptidyl peptidase-4 enzyme and selenium element in people with kidney failure in Kirkuk governorate
  Ibrahim Abdullah Ali Al-Jubouri, Nadia Ahmed Saleh Al-Jubouri
  Materials Today: Proceedings.2022; 60: 795.     CrossRef
• Cardiovascular Effects of Incretin-Based Therapies: Integrating Mechanisms With Cardiovascular Outcome Trials
  John R. Ussher, Amanda A. Greenwell, My-Anh Nguyen, Erin E. Mulvihill
  Diabetes.2022; 71(2): 173.     CrossRef
• Computer-Aided Screening of Phytoconstituents from Ocimum tenuiflorum against Diabetes Mellitus Targeting DPP4 Inhibition: A Combination of Molecular Docking, Molecular Dynamics, and Pharmacokinetics Approaches
  Harshit Sajal, Shashank M. Patil, Ranjith Raj, Abdullah M. Shbeer, Mohammed Ageel, Ramith Ramu
  Molecules.2022; 27(16): 5133.     CrossRef
• Association Between DPP4 Inhibitor Use and the Incidence of Cirrhosis, ESRD, and Some Cancers in Patients With Diabetes
  Yewon Na, Soo Wan Kim, Ie Byung Park, Soo Jung Choi, Seungyoon Nam, Jaehun Jung, Dae Ho Lee
  The Journal of Clinical Endocrinology & Metabolism.2022; 107(11): 3022.     CrossRef
• An update on the interaction between COVID-19, vaccines, and diabetic kidney disease
  Yang Yang, Shubiao Zou, Gaosi Xu
  Frontiers in Immunology.2022;[Epub]     CrossRef
• Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus
  Kyung-Soo Kim, Sangmo Hong, Hong-Yup Ahn, Cheol-Young Park
  Diabetes Therapy.2021; 12(1): 171.     CrossRef
• Renoprotective Effects of DPP-4 Inhibitors
  Daiji Kawanami, Yuichi Takashi, Hiroyuki Takahashi, Ryoko Motonaga, Makito Tanabe
  Antioxidants.2021; 10(2): 246.     CrossRef
• Serum levels of soluble dipeptidyl peptidase-4 in type 2 diabetes are associated with severity of liver fibrosis evaluated by transient elastography (FibroScan) and the FAST (FibroScan-AST) score, a novel index of non-alcoholic steatohepatitis with signif
  Masaaki Sagara, Toshie Iijima, Masato Kase, Kanako Kato, Shintaro Sakurai, Takuya Tomaru, Teruo Jojima, Isao Usui, Yoshimasa Aso
  Journal of Diabetes and its Complications.2021; 35(5): 107885.     CrossRef
• Distinctive CD26 Expression on CD4 T-Cell Subsets
  Oscar J. Cordero, Carlos Rafael-Vidal, Rubén Varela-Calviño, Cristina Calviño-Sampedro, Beatriz Malvar-Fernández, Samuel García, Juan E. Viñuela, José M. Pego-Reigosa
  Biomolecules.2021; 11(10): 1446.     CrossRef
• The Long-Term Study of Urinary Biomarkers of Renal Injury in Spontaneously Hypertensive Rats
  Sebastián Montoro-Molina, Andrés Quesada, Francisco O’Valle, Natividad Martín Morales, María del Carmen de Gracia, Isabel Rodríguez-Gómez, Antonio Osuna, Rosemary Wangensteen, Félix Vargas
  Kidney and Blood Pressure Research.2021; 46(4): 502.     CrossRef
• Serum Dipeptidyl peptidase-4 level is related to adiposity in type 1 diabetic adolescents
  Amany Ibrahim, Shaimaa Salah, Mona Attia, Hanan Madani, Samah Ahmad, Noha Arafa, Hend Soliman
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2020; 14(4): 609.     CrossRef
• Phase I study of YS110, a recombinant humanized monoclonal antibody to CD26, in Japanese patients with advanced malignant pleural mesothelioma
  Masayuki Takeda, Yuichiro Ohe, Hidehito Horinouchi, Toyoaki Hida, Junichi Shimizu, Takashi Seto, Kaname Nosaki, Takumi Kishimoto, Itaru Miyashita, Masayuki Yamada, Yutaro Kaneko, Chikao Morimoto, Kazuhiko Nakagawa
  Lung Cancer.2019; 137: 64.     CrossRef

Citations

Citations to this article as recorded by  

• Homocysteine and diabetes: Role in macrovascular and microvascular complications
  Emir Muzurović, Ivana Kraljević, Mirsala Solak, Siniša Dragnić, Dimitri P. Mikhailidis
  Journal of Diabetes and its Complications.2021; 35(3): 107834.     CrossRef
• Associations of Homocysteine with B Vitamins and Zinc in Serum Levels of Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study
  Sadako MATSUI, Chika HIRAISHI, Ryo SATO, Takai KOJIMA, Kiyotaka ANDO, Kei FUJIMOTO, Hiroshi YOSHIDA
  Journal of Nutritional Science and Vitaminology.2021; 67(6): 417.     CrossRef
• A risk scoring system for the decreased glomerular filtration rate in Chinese general population
  Yan Gu, Min Chen, Bei Zhu, Xiaohua Pei, Zhenzhu Yong, Xiaona Li, Qun Zhang, Weihong Zhao
  Journal of Clinical Laboratory Analysis.2020;[Epub]     CrossRef
• Relationship between plasma total homocysteine and the severity of renal function in Chinese patients with type 2 diabetes mellitus aged ≥75 years
  Ning Ma, Ning Xu, Dong Yin, Weiwei Liu, Mengping Wu, Xingbo Cheng
  Medicine.2020; 99(27): e20737.     CrossRef
• Correlation between serum homocysteine level and ulcerative colitis: A meta-analysis
  Yifang Zhong, Feng Yan, Weixia Jie, Ying Zhou, Fang Fang
  Pteridines.2019; 30(1): 114.     CrossRef
• The role of molecular genetic alterations in genes involved in folate and homocysteine metabolism in multifactorial diseases pathogenesis
  A. M. Burdennyy, V. I. Loginov, T. M. Zavarykina, E. A. Braga, A. A. Kubatiev
  Russian Journal of Genetics.2017; 53(5): 528.     CrossRef
• МОЛЕКУЛЯРНО-ГЕНЕТИЧЕСКИЕ НАРУШЕНИЯ ГЕНОВ ФОЛАТНОГО И ГОМОЦИСТЕИНОВОГО ОБМЕНА В ПАТОГЕНЕЗЕ РЯДА МНОГОФАКТОРНЫХ ЗАБОЛЕВАНИЙ, "Генетика"
  А. М. Бурдённый, В.И. Логинов, Т.М. Заварыкина, Э.А. Брага, А.А. Кубатиев
  Генетика.2017; (5): 526.     CrossRef
• Association Between Plasma Homocysteine and Microalbuminuria in Untreated Patients with Essential Hypertension: a Case-Control Study
  Ze-min Kuang, Ying Wang, Shu-jun Feng, Long Jiang, Wen-li Cheng
  Kidney and Blood Pressure Research.2017; 42(6): 1303.     CrossRef
• NMDA Receptors as Potential Therapeutic Targets in Diabetic Nephropathy: Increased Renal NMDA Receptor Subunit Expression in Akita Mice and Reduced Nephropathy Following Sustained Treatment With Memantine or MK-801
  Hila Roshanravan, Eun Young Kim, Stuart E. Dryer
  Diabetes.2016; 65(10): 3139.     CrossRef
• Association between homocysteine status and the risk of nephropathy in type 2 diabetes mellitus
  Song Mao, Wei Xiang, Songming Huang, Aihua Zhang
  Clinica Chimica Acta.2014; 431: 206.     CrossRef
• Prevalence and Determinants of Diabetic Nephropathy in Korea: Korea National Health and Nutrition Examination Survey
  Jae Hee Ahn, Ji Hee Yu, Seung-Hyun Ko, Hyuk-Sang Kwon, Dae Jung Kim, Jae Hyeon Kim, Chul Sik Kim, Kee-Ho Song, Jong Chul Won, Soo Lim, Sung Hee Choi, Kyungdo Han, Bong-Yun Cha, Nan Hee Kim
  Diabetes & Metabolism Journal.2014; 38(2): 109.     CrossRef
• Plasma Homocysteine level and its clinical correlation with type 2 diabetes mellitus and its complications
  Satyendra Kumar Sonkar, Gyanendra Kumar Sonkar, Deepika Soni, Dheeraj Soni, Kauser Usman
  International Journal of Diabetes in Developing Countries.2014; 34(1): 3.     CrossRef
• Genetic Predisposition for Development of Nephropathy in Type 2 Diabetes Mellitus
  Ravindra Kumar, Raj Kumar Sharma, Sarita Agarwal
  Biochemical Genetics.2013; 51(11-12): 865.     CrossRef
• Is C677T Polymorphism in Methylenetetrahydrofolate Reductase Gene a Risk Factor for Diabetic Nephropathy or Diabetes Mellitus in a Chinese Population?
  Wen-peng Cui, Bing Du, Ye Jia, Wen-hua Zhou, Sheng-mao Liu, Ying-chun Cui, Fu-zhe Ma, Ping Luo, Li-ning Miao
  Archives of Medical Research.2012; 43(1): 42.     CrossRef
• The role of coagulation and inflammation in the development of diabetic nephropathy in patients withdiabetes mellitus type 2
  Yulia Valer'evna Khasanova, Alsu Asatovna Nelaeva, Anna Borisovna Galkina, Irina Vasil'evna Medvedeva
  Diabetes mellitus.2012; 15(1): 31.     CrossRef